Prof. Lukas Kenner has been appointed as member of the Research Advisory Committee of Prostate Cancer UK. In this position he will advise the Board of Trustees and Chief Executive of the Charity on its research strategies and policies, and to make recommendations as to which research grants the charity should support.
Prostate Cancer UK invests more than 10 M€ annually towards innovative research to to implement its 10 year research strategy. Prostate Cancer UK will create a step change in our knowledge of prostate cancer towards being smarter in how we detect and treat prostate cancer at every stage, and to develop personalised approaches for every man to achieve the best outcome. Prof. Kenner with his research portfolio and expertise fully supports these goals and all members of the LBI-CR congratulate him to this appointment.